Cadila Healthcare has informed that Ganesh N. Nayak (DIN00017481) was appointed as the Whole Time Director and Chief Operating Officer of the Company for a period of 1 year with effect from July 12, 2020 and his term will expire on July 11, 2021. The Board of Directors at their meeting held today July 9, 2021, based on the recommendation of the Nomination and Remuneration Committee, approved re-appointment of Ganesh N. Nayak, as the Executive Director of the Company for a period of 3 years with effect from July 12, 2021. He shall be liable to retire by rotation. The said re-appointment shall be subject to approval of the shareholders at the ensuing Annual General Meeting by way of an Ordinary Resolution. Ganesh N. Nayak is not related to any of the Directors of the Company. He is not debarred from holding the office of director pursuant to any SEBI Order or any other authority. Brief profile of Ganesh N. Nayak is enclosed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.25 |
| Dr. Reddys Labs. | 1245.50 |
| Cipla | 1438.75 |
| Zydus Lifesciences | 1150.50 |
| Lupin | 2496.05 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: